The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

NCT01354093 · clinicaltrials.gov ↗

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Juxtafoveal Telangiectasia

Interventions

DRUG: zeaxanthin
DRUG: zeaxanthin

Sponsor

Paul S. Bernstein